MRK
Merck & Co., Inc.
NYSE · Healthcare · Drug Manufacturers - General · US
$146.53
+1.29%Margins
Gross margin
77.0%
EBITDA margin
19.4%
EBIT margin
16.2%
Net margin
3.6%
FCF margin
18.4%
—
Return on equity
—
Return on assets
—
Return on invested capital
—
Asset turnover
$16.5B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026